A prospective, randomized, active controlled, parallel group, multi-center trial to assess the efficacy and safety of mycophenolate mofetil (MMF) in inducing response and maintaining remission in subjects with lupus nephritis. - Aspreva Lupus Management Study (ALMS)
A prospective, randomized, active controlled, parallel group, multi-center trial to assess the efficacy and safety of mycophenolate mofetil (MMF) in inducing response and maintaining remission in subjects with lupus nephritis. - Aspreva Lupus Management Study (ALMS)
100 项与 Aspreva International Ltd. 相关的临床结果
0 项与 Aspreva International Ltd. 相关的专利（医药）
100 项与 Aspreva International Ltd. 相关的药物交易
100 项与 Aspreva International Ltd. 相关的转化医学
